Cristina Larkin

Track

Insider profile

Currently holds a position at Spero Therapeutics Inc

Positions

Position Company Period
Chief Operating Officer and Chief Commercial Officer Spero Therapeutics Inc Sept. 1, 2017 -
Chief Commercial Officer Spero Therapeutics Inc None -
Cristina Larkin's trades of Spero Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
141.75
Quantity 18,865 -1.6%
Value US$3,064,088
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-12-18 2020-12-16
PlS Planned sale
18,865 -1.6%
141.75
US$3,064,088 		18,865 -1.6% 141.75 US$3,064,088